Role of the BRM- ERα interaction in the conferring of resistance to paclitaxel in BRG1-deficient cancers
2025/57/N/NZ7/02078
Keywords
Descriptors
- NZ7_08: Skuteczność terapii, w tym oporność na terapie
Panel
NZ7 – Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution
Uniwersytet Łódzki
Voivodeship: łódzkie
Principal investigator (from the host institution)
Number of co-investigators in the project: 3
Call
PRELUDIUM 24 – announced on 2025-03-17
- Amount awarded
- 139 920 PLN
- Project start date
- 2026-02-09
- Project end date
- 2028-02-08
- Project duration
- 24 months (the same as in the proposal)
- Project status
- Pending project
Project description
Download the project description in a pdf file
Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.